INNOVATIVE THERAPY FOR RHEUMATOID ARTHRITIS

3615396Rheumatoid arthritis is an autoimmune disease common in middle age, especially in women. The disease affects peripheral joints, including the wrists, feet, ankles, and knees. The cause is unknown and eyes and skin also can be involved. Early aggressive therapy with immunosuppressive drugs and antiinflammatories appears to delay joint destruction. More recently, biologic agents have been added to regimens that include TNF inhibitors, WBC modulators, and growth factor inhibitors. Research is ongoing to evaluate the effects of cells on auto-immune conditions. According to the Journal of Translational Research, “The ability of MSC to inhibit immune response, while offering the possibility of inducing/accelerating healing of tissue that has already been damaged, makes this population attractive for treatment of autoimmune disorders.”

Cells And Rheumatoid Arthritis

Adipose or fat derived cells have been shown to halt arthritic conditions and, in many cases, reverse and regenerate joint tissue. Cell treatments have been shown to cut the destruction of cartilage by 54% and after six weeks reduced ligament damage and inflammation by 30%.

Rheumatoid arthritis, as it worsens, is the end-result of your body having an autoimmune response and attacks your own cells, creating a constant proinflammatory state. Our innovative treatment for Rheumatoid arthritis increases the healing of your joints, AND it goes further and treats the entire system that is causing the joint pain and inflammation.

The entire cellular surgical procedure takes approximately three hours.